NEW YORK (GenomeWeb) – An international team of researchers has found that the polygenic nature of schizophrenia may make polygenic risk scoring (PRS) a valuable predictor of the efficacy of antipsychotic drugs in schizophrenic patients suffering from a first episode of psychosis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.